Shire Billed Medicaid For Off-Label ADHD Drug Use, La. Says

Law360, New York (August 20, 2013, 6:07 PM EDT) -- Irish drugmaker Shire PLC and its U.S. unit were targeted by the Louisiana attorney general in a suit removed to federal court Monday that claims they promoted certain attention deficit hyperactivity disorder drugs for off-label uses and obtained federal Medicare reimbursements for such improper use.

The drugmaker argued the suit belongs in federal court because it involves federal issues including alleged violations of the Federal Food, Drug, and Cosmetic Act, as well as Shire’s alleged submission of false claims to Medicaid for ADHD prescriptions that were...
To view the full article, register now.